CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- 4 Planned sale Chair and CEO sold 135,009 shares at an average $100.39 ($13,553,744)
- 4 Planned sale Chief Operating Officer sold 10,686 shares at an average $98.82 ($1,056,004)
- 4 Planned sale Chief Medical Officer sold 45,163 shares at an average $91.16 ($4,117,067)
- 4 Planned sale Chief People Strategy Officer sold 137,472 shares at an average $92.09 ($12,659,257)
- 4 Planned sale Chief Financial Officer sold 57,766 shares at an average $89.12 ($5,148,024)
- 4 Planned sale Chief Legal Officer sold 1,879 shares at $73.50 ($138,107)
- 4 Open-market sale Chief Legal Officer sold 1,448 shares at $71.50 ($103,532)
- 4 Open-market sale Chief Medical Officer sold 1,686 shares at $71.50 ($120,549)
- 4 Open-market sale Chief Operating Officer sold 1,860 shares at $71.50 ($132,990)
- 4 Open-market sale Chief Financial Officer sold 1,579 shares at $71.50 ($112,899)
- 4 Open-market sale Chief People Strategy Officer sold 1,642 shares at $71.50 ($117,403)
- 4 Planned sale Director sold 6,250 shares at an average $72.25 ($451,535)
- 4 Planned sale Chair and CEO sold 12,302 shares at an average $71.39 ($878,292)
- 4 Planned sale Chief Legal Officer sold 26,327 shares at an average $69.65 ($1,833,779)
- 4 Gift Director gave 200 shares (gift)
- 4 Gift Director gave 400 shares (gift)
- 4 Open-market buy Director bought 3,025 shares at an average $66.68 ($201,694)
- 4 Planned sale Chair and CEO sold 27,887 shares at an average $67.66 ($1,886,957)
- 4 Grant or award Chief Financial Officer acquired 6,508 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 6,508 shares (grant or award)
Page 6 of 40 · 788 filings